Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3444  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  ╗ Next article
  ╗ Previous article 
  ╗ Table of Contents
  
 Resource Links
  ╗  Similar in PUBMED
 ╗  Search Pubmed for
 ╗  Search in Google Scholar for
  ╗  Article in PDF (265 KB)
  ╗  Citation Manager
  ╗  Access Statistics
  ╗  Reader Comments
  ╗  Email Alert *
  ╗  Add to My List *
* Registration required (free)  

 
  In this Article
   References

 Article Access Statistics
    Viewed1460    
    Printed65    
    Emailed1    
    PDF Downloaded121    
    Comments [Add]    

Recommend this journal

 


 
INVITED COMMENTARY
Year : 2009  |  Volume : 57  |  Issue : 3  |  Page : 303-304

Invited Commentary


Servicio de ReumatologÝa, Hospital del Mary Hospital de la Esperanza, Institut Municipal d'AssistŔncia SanitÓria, Barcelona, Spain

Date of Acceptance12-Apr-2009
Date of Web Publication8-Jul-2009

Correspondence Address:
D Taverner
Servicio de ReumatologÝa, Hospital del Mar y Hospital de la Esperanza, Institut Municipal d'AssistŔncia SanitÓria, Barcelona
Spain
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions



How to cite this article:
Taverner D. Invited Commentary. Neurol India 2009;57:303-4

How to cite this URL:
Taverner D. Invited Commentary. Neurol India [serial online] 2009 [cited 2021 Jan 26];57:303-4. Available from: https://www.neurologyindia.com/text.asp?2009/57/3/303/53290


Carpal tunnel syndrome is one of the most common peripheral entrapment neuropathies and is associated with substantial direct medical costs and with economic costs in terms of man day loss and possible continuing disability. [1] Workers employed in occupations involving exposure to high pressure, high force, repetitive work, and vibrating tools are most at risk for developing carpal tunnel syndrome. [2] Some reports indicate that the incidence of this syndrome is increasing. [3]

A patient with mild symptoms of carpal tunnel syndrome can be managed with conservative treatment, particularly local injection of corticosteroids with or without insulin, splinting of the wrist, ultrasonic therapy, physical therapy, acupuncture, diuretics, oral vitamin B6, non-steroidal anti-inflammatory drugs, or antiepileptic drugs. However, in moderate to severe cases and cases unresponsive to conservative measures can be managed surgically with carpal tunnel release.[4],[5] Even though surgery for carpal tunnel syndrome is generally considered safe and effective, the possible risk associated with surgery and the potential for complications may contribute to the preference of some patients for nonsurgical treatment.

The chronic form of carpal tunnel syndrome is the most common form and symptoms can persist for months to years. However, in only 50% of cases is the cause identified, and can be divided into local, regional and systemic causes. It is very important to know if the carpal tunnel syndrome is primary or idiopathic or secondary to an underlying cause to choose the treatment. In the article by Erdemoglu et al ., [6] a comprehensive medical and neurological evaluation was performed in order to exclude neuropathy of other etiologies.

Gabapentin is an antiepileptic drug approved by the Food and Drug Administration as a first-line and as an adjunctive agent for the treatment of partial seizures. It has been also reported to be effective in several series of patients with different types of pain syndromes (e.g., neuropathic pain, postherpetic neuralgia etc.). [7] Several studies that have been published try to demonstrate the effectiveness and the safety of antiepileptic treatments like gabapentin in the neuropathic pain of carpal tunnel syndrome. Taverner et al ., [8] found that gabapentin was effective in the reduction of pain and improvement of the severity of the symptom. The drug was safe and well tolerated. In this study the dosage and titration of gabapentin was similar to the other study and the side-effects were transient and mild. The most frequent side-effect was dizziness and nausea.

Finally, the authors use a self-administered questionnaire for the assessment of the severity of symptoms and functional status in patients who have carpal tunnel syndrome. [6] Levine et al ., [9] concluded that the scales for the measurement of symptoms' severity and functional status are reproducible, internally consistent, and responsive to clinical change, and that they measure dimensions of outcomes internally. They recommended that the scales should enhance standardization of measurement of outcomes in studies of treatment for carpal tunnel syndrome.

 
 ╗ References Top

1.Shaw Wilgis EF. Treatment options for carpal tunnel syndrome. JAMA 2002;288:1281-2.  Back to cited text no. 1    
2.Viikari-Juntura E, Silverstein B. Role of physical load factors in carpal tunnel syndrome. Scand J Work Environ Health 1999;25:163-85.  Back to cited text no. 2    
3.Rossignol M, Stock S, Patry L, Armstrong B. Carpal tunnel syndrome: What is a attributable to work? the Montreal study. Occup Environ Med 1997;54:519-23.  Back to cited text no. 3    
4.Aroori S, Spence RA. Carpal tunnel syndrome. Ulster Med J 2008;77:6-17.  Back to cited text no. 4    
5.Katz JN, Keller RB, Simmons BP, Rogers WD, Bessette L, Fossel AH, et al. Maine carpal tunnel study: Outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort. J Hand Surg Am 1998;23:697-710.  Back to cited text no. 5    
6.Erdemoglu AK, Varlihas A. Open label trial: The efficacy and safety of gabapentin in carpal tunnel patients. Neurol India 2009;57:290-3.  Back to cited text no. 6    
7.Serrao M, Rossi P, Cardinali P, Valente G, Parisi L, Pierelli F. Gabapentin treatment for muscle cramps: An open-label trial. Clin Neuropharmacol 2000;23:45-9.  Back to cited text no. 7    
8.Taverner D, Lisbona MP, Segalιs N, Docampo E, Calvet J, Castro S, et al. Eficacia de la gabapentina en el tratamiento del sνndrome del t˙nel carpiano. Med Clin (Barc) 2008;130:371-3.  Back to cited text no. 8    
9.Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, et al. A self-administered questionnaire for the assessment of severty of symptoms and functional status in carpal tunnel sνndrome. J Bone Joint Surg Am 1993;75:1585-92.  Back to cited text no. 9    




 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow